Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Dexcom (DXCM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 13,154,691
  • Shares Outstanding, K 90,002
  • Annual Sales, $ 1,032 M
  • Annual Income, $ -127,100 K
  • 60-Month Beta 0.78
  • Price/Sales 12.82
  • Price/Cash Flow 234.80
  • Price/Book 19.68

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.17
  • Number of Estimates 10
  • High Estimate 0.18
  • Low Estimate -0.60
  • Prior Year -0.32
  • Growth Rate Est. (year over year) +46.88%

Price Performance

See More
Period Period Low Period High Performance
1-Month
135.22 +6.48%
on 02/22/19
156.16 -7.80%
on 02/22/19
-2.27 (-1.55%)
since 02/21/19
3-Month
105.71 +36.20%
on 12/24/18
156.16 -7.80%
on 02/22/19
+35.66 (+32.92%)
since 12/21/18
52-Week
66.73 +115.77%
on 03/22/18
156.16 -7.80%
on 02/22/19
+76.27 (+112.64%)
since 03/21/18

Most Recent Stories

More News
Is DexCom (DXCM) Outperforming Other Medical Stocks This Year?

Is (DXCM) Outperforming Other Medical Stocks This Year?

DXCM : 143.75 (-1.65%)
Inogen's Prospects in Europe Solid Amid Trade-Related Tension

Inogen's (INGN) business-to-business unit sees strength in Europe.

WMGI : 32.35 (+0.72%)
PEN : 159.96 (+1.40%)
INGN : 94.34 (+1.15%)
DXCM : 143.75 (-1.65%)
Veeva Systems (VEEV) Gains From Solid Results for Fiscal Q4

Veeva Systems' (VEEV) broad spectrum of products include Veeva Vault, Veeva CRM, Veeva Network and Veeva OpenData.

WMGI : 32.35 (+0.72%)
VEEV : 127.77 (+2.57%)
PEN : 159.96 (+1.40%)
DXCM : 143.75 (-1.65%)
Best Relative Performance in the Health Care Equipment Industry Detected in Shares of Tandem Diabetes (TNDM, OXFD , DXCM , IDXX , EW )

Here are the top 5 stocks in the Health Care Equipment industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

OXFD : 18.08 (+0.78%)
TNDM : 74.18 (+3.49%)
DXCM : 143.75 (-1.65%)
After Yesterday's Rally of 3.45% Shares Could Potentially Pullback

Dexcom (NASDAQ:DXCM) traded in a range yesterday that spanned from a low of $146.31 to a high of $148.75. Yesterday, the shares gained 3.4%, which took the trading range above the 3-day high of $145.05...

DXCM : 143.75 (-1.65%)
Varian & Tata Trust Tie Up to Boost Radiotherapy in India

Varian's (VAR) three-year deal with Tata Trust is likely to fortify its foothold in the Asia-Pacific radiotherapy space.

SYK : 198.60 (+0.74%)
VAR : 137.57 (+1.29%)
ARAY : 4.92 (+1.44%)
DXCM : 143.75 (-1.65%)
The Zacks Analyst Blog Highlights: Jazz Pharmaceuticals, Lululemon Athletica, ABIOMED and DexCom

The Zacks Analyst Blog Highlights: Jazz Pharmaceuticals, Lululemon Athletica, ABIOMED and DexCom

LULU : 148.43 (+2.83%)
JAZZ : 136.41 (+2.13%)
ABMD : 344.36 (+1.38%)
DXCM : 143.75 (-1.65%)
Tech Snaps Market Out of Slump

Tech Snaps Market Out of Slump

TROX : 12.95 (+0.39%)
SYF : 33.00 (+1.69%)
LYV : 64.17 (+1.62%)
VEEV : 127.77 (+2.57%)
BAH : 57.75 (+1.69%)
CBRE : 49.72 (+0.71%)
DAL : 50.34 (+0.94%)
HTZ : 17.33 (+1.76%)
COST : 238.17 (+0.50%)
SPR : 92.01 (+0.60%)
PRFT : 28.35 (+1.00%)
RCII : 19.87 (+3.98%)
ANTM : 303.39 (+0.13%)
CHTR : 367.10 (+1.29%)
FB : 164.84 (-0.36%)
DXCM : 143.75 (-1.65%)
BA : 374.04 (-0.56%)
The Best And Worst Stocks of the 10-Year Bull Market

We highlight some of the best and worst stocks over the bull market's 10 years.

NFLX : 375.01 (-0.06%)
RIG : 9.49 (+0.32%)
LULU : 148.43 (+2.83%)
AAPL : 194.67 (+3.46%)
WFT : 0.78 (-2.50%)
JAZZ : 136.41 (+2.13%)
ABMD : 344.36 (+1.38%)
CHK : 3.24 (-0.61%)
RHHBY : 34.0050 (-0.25%)
DXCM : 143.75 (-1.65%)
HOLX vs DXCM: Which MedTech Stock is a Better Investment Pick?

DexCom (DXCM) looks stronger than Hologic (HOLX) when it comes to current-year earnings and revenue projections as well as fundamentals.

HOLX : 47.63 (+0.70%)
ITGR : 86.48 (+1.25%)
VEEV : 127.77 (+2.57%)
DXCM : 143.75 (-1.65%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade DXCM with:

Business Summary

Dexcom Inc. is developing continuous glucose monitoring systems for people with diabetes.

See More

Key Turning Points

2nd Resistance Point 149.42
1st Resistance Point 147.79
Last Price 143.75
1st Support Level 144.82
2nd Support Level 143.48

See More

52-Week High 156.16
Last Price 143.75
Fibonacci 61.8% 122.00
Fibonacci 50% 111.45
Fibonacci 38.2% 100.89
52-Week Low 66.73

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar